1. Home
  2. Analysis
  3. Proair-hfa
  4. Intelence

Proair hfa and Intelence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proair hfa (albuterol sulfate) and Intelence (etravirine). Common drug interactions include chronic kidney disease among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Proair hfa and Intelence. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

On Jul, 15, 2026

30 people who take Proair hfa and Intelence together, and have interactions are studied.

Proair hfa and Intelence drug interactions.

What are the common drug interactions of Proair Hfa and Intelence, by gender? *:

female:

  1. Chronic kidney disease
  2. Bone density decreased
  3. Emotional distress
  4. Pain
  5. Tooth loss
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Asthenia (weakness)
  9. Depression
  10. Renal failure (kidney dysfunction)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal failure (kidney dysfunction)
  4. Decreased activity
  5. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  6. Quality of life decreased
  7. Arthralgia (joint pain)
  8. Bone pain
  9. Drug resistance (reduction in effectiveness of a drug)
  10. Death

What are the common drug interactions of Proair Hfa and Intelence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Death
  3. Decreased activity
  4. Emotional distress
  5. Fear
  6. Impaired work ability
  7. Pain
  8. Quality of life decreased
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone disorder
  4. Chronic kidney disease
  5. Decreased activity
  6. Emotional distress
  7. Osteonecrosis (death of bone)
  8. Pain
  9. Quality of life decreased

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Pain
  6. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  7. Renal impairment (severely reduced kidney function)
  8. Bone pain
  9. Drug resistance (reduction in effectiveness of a drug)
  10. Gait disturbance

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Bone density decreased
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis (bones weak and more likely to break)
  8. Arthralgia (joint pain)
  9. Renal failure (kidney dysfunction)
  10. Asthenia (weakness)

60+:

  1. Emotional distress
  2. Pain
  3. Jaw fracture
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Osteoporosis (bones weak and more likely to break)
  6. Rib fracture
  7. Tooth fracture
  8. Tooth loss
  9. Upper limb fracture
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Hiv Infection: 27 people, 90.00%
  2. Pain: 7 people, 23.33%
  3. High Blood Cholesterol: 5 people, 16.67%
  4. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 4 people, 13.33%
  5. Depression: 4 people, 13.33%
  6. Diabetes: 4 people, 13.33%
  7. Hypersensitivity: 4 people, 13.33%
  8. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 10.00%
  9. Dry Skin: 3 people, 10.00%
  10. Dyspnea (difficult or laboured breathing): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and Intelence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Proair hfa and Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intelence and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and etravirine (the active ingredients of Proair hfa and Intelence, respectively), and Proair hfa and Intelence (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.